CN1137713C - Chinese medicine oral preparation for curing apoplectic disease-Suyusan and its preparation method - Google Patents
Chinese medicine oral preparation for curing apoplectic disease-Suyusan and its preparation method Download PDFInfo
- Publication number
- CN1137713C CN1137713C CNB011184973A CN01118497A CN1137713C CN 1137713 C CN1137713 C CN 1137713C CN B011184973 A CNB011184973 A CN B011184973A CN 01118497 A CN01118497 A CN 01118497A CN 1137713 C CN1137713 C CN 1137713C
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- radix
- rhizoma
- oral drugs
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to an oral medicine, i.g. Suyu powder for treating apoplexy, which is prepared from calamus, uncaria, chrysanthemum, curcuma root, common aucklandia root, angelica, hemlock parsley, salvia miltiorrhiza, safflower, pinellia tuber, dried tangerine peel, stiff silkorm and earthworm. Raw materials are extracted, concentrated and dried to obtain oral medicine powder of fine powder. The medicine for treating apoplexy is a pure traditional Chinese medicine preparation which has the advantages of rapid curative effect, short therapeutic period, good curative effect, convenient administration and no side effect.
Description
The present invention relates to a kind of oral drugs and manufacture method thereof for the treatment of the internal medicine disease, particularly relate to a kind of oral drugs medicine ' Suyusan ' for treating and manufacture method thereof for the treatment of apoplexy.
Apoplexy is a kind of common internal medicine disease, and is commonplace, and it is wide to distribute, sickness rate is on the rise in recent years, and particularly China's population has stepped into aging country, and aged's ratio increases year by year, the apoplexy sickness rate also rises year by year, serious harm masses physical and mental health.Along with the Chinese society constant development of economy, people's living standard improves constantly, and dietary habit has very big change, work strain in addition, and environmental pollution is on the rise, and causes the apoplexy sickness rate to increase day by day, sequela is in various degree arranged, the lighter's deformity after patient's morbidity; Weight person can't take care of oneself, as half body not with, severe patient is unable to leave the bed or is dead in a short time.It is the difficult pertinacious disease of a kind of internal medicine of generally acknowledging both at home and abroad.Though current this sick method of treatment and medicine are a lot, can not reach desirable curative effect.For example: the molten Therapeutic Method such as therapy and anticoagulant therapy of fastening of doctor trained in Western medicine, not only weak curative effect, slow, the shortcoming such as the treatment phase is long that takes effect, but also can cause subcutaneous hemorrhage, side effect such as gastrointestinal hemorrhage, cerebral hemorrhage.For example add and use the snake venom antithrombotic enzyme intravenous drip, because human body is different, the effect of snake venom dredge the meridian passage is stronger, the property strengthened forces flow to increase, cerebral hemorrhage easily takes place, and in addition, the toxicity of snake venom own is bigger, to some side effect of human body existing damaging tissue effect and reduction human immunity, total therapeutic effect is unsatisfactory.
The objective of the invention is in order to overcome above-mentioned weak point, provide a kind of study intensively for many years through the inventor provide a kind of with long-term clinical practice and have that instant effect, treatment phase are short, the oral drugs medicine ' Suyusan ' for treating and the manufacture method thereof of effective percentage and cure rate height, easy to use, the treatment apoplexy that has no side effect.
A kind of oral drugs medicine ' Suyusan ' for treating for the treatment of apoplexy provided by the invention, comprise following materials of weight proportions medicament, through extracting, concentrate, dry and the oral drugs powder made: Rhizoma Acori Graminei 8-15 part Ramulus Uncariae Cum Uncis 1.2-2.5 part Flos Chrysanthemi 1.1-2.5 part Radix Curcumae 1-3 part Radix Aucklandiae 1.6-2.5 part Radix Angelicae Sinensis 0.7-1.5 part Rhizoma Chuanxiong 0.5-1.5 part Radix Salviae Miltiorrhizae 8-15 part Flos Carthami 1.8-2.4 part Rhizoma Pinelliae 0.4-1.3 part Pericarpium Citri Reticulatae 0.6-1.5 part Bombyx Batryticatus 0.8-1.5 part Pheretima 0.3-1.4 part
A kind of treatment apoplexy oral drugs medicine ' Suyusan ' for treating provided by the invention, the weight proportion of preferred raw material medicament is: Rhizoma Acori Graminei 9-13 part Ramulus Uncariae Cum Uncis 1.5-2.3 part Flos Chrysanthemi 1.2-2.3 part Radix Curcumae 1.8-2.5 part Radix Aucklandiae 1.8-2.3 part Radix Angelicae Sinensis 0.9-1.3 part Rhizoma Chuanxiong 0.6-1.3 part Radix Salviae Miltiorrhizae 9-15 part Flos Carthami 1.9-2.3 part Rhizoma Pinelliae 0.6-1.2 part Pericarpium Citri Reticulatae 0.7-1.4 part Bombyx Batryticatus 0.9-1.4 part Pheretima 0.4-11 part
In a kind of treatment apoplexy oral drugs medicine ' Suyusan ' for treating provided by the invention, preferred raw material medicament weight proportion is: 1 part of 1 part of Pheretima of 1 part of Bombyx Batryticatus of 1 part of Pericarpium Citri Reticulatae of 2 parts of Rhizoma Pinelliaes of 10 parts of Flos Carthamis of 1 part of Radix Salviae Miltiorrhizae of 1 part of Rhizoma Chuanxiong of 2 parts of Radix Angelicae Sinensis of 2 parts of Radix Aucklandiae of 2 portions of Radix Curcumaes of 2 parts of Flos Chrysanthemis of 10 parts of Ramulus Uncariae Cum Uncis of Rhizoma Acori Graminei
In treatment apoplexy oral drugs medicine ' Suyusan ' for treating provided by the invention, described raw material medicament, Rhizoma Acori Graminei, Ramulus Uncariae Cum Uncis, Flos Chrysanthemi are monarch drug, have have one's ideas straightened out, refreshment, cephalocathartic, the effect of dispeling the wind, be supporting vital QI to relieve the primary cause of disease.
Radix Curcumae, the Radix Aucklandiae are ministerial drug, have the repercussive eliminating stagnation, regulate the flow of vital energy and remove stagnant effect, can help monarch drug and reach the effect of raising curative effect.
Radix Angelicae Sinensis, Rhizoma Chuanxiong, Flos Carthami, Radix Salviae Miltiorrhizae, the Rhizoma Pinelliae, Pericarpium Citri Reticulatae are adjuvant drug, have blood circulation promoting and blood stasis dispelling, microcirculation improvement, dehumidifying expectorant dual function.
With Bombyx Batryticatus, Pheretima is messenger drug, has dredge the meridian passage, an effect of dispeling the wind, and can draw all medicines return through.
Because above-mentioned monarch drug, ministerial drug, adjuvant drug and messenger drug are with full side's compatibility, coordinated has inducing resuscitation mutually, and collateral dredging is invigorated blood circulation, and eliminating impediment reduces phlegm, the effect of dispelling wind-evil and transforming calculus; Quick microcirculation improvement, raise immunity, thus improved therapeutic effect.
Manufacture method according to treatment apoplexy oral drugs medicine ' Suyusan ' for treating provided by the invention comprises the following steps:
(1) extracts Chinese medicine decoction
With Rhizoma Acori Graminei, Ramulus Uncariae Cum Uncis, Flos Chrysanthemi, Radix Curcumae, the Radix Aucklandiae, Radix Angelicae Sinensis, Rhizoma Chuanxiong, Radix Salviae Miltiorrhizae, Flos Carthami, the Rhizoma Pinelliae, Pericarpium Citri Reticulatae, Bombyx Batryticatus, Pheretima, put into the Chinese medicine extraction jar by described weight proportion and appropriate amount of purified water, use conventional extraction method, extract Chinese medicine decoction.
(2) concentrate
The Chinese medicine decoction that above-mentioned steps (1) is obtained with the normal pressure concentration tank routinely method refine into the Chinese medicine unguentum.
(3) spray drying
The Chinese medicine unguentum that above-mentioned steps (2) is obtained is spray dried to the meticulous powder oral drugs of Chinese medicine powder with spray drying device.
(4) fill becomes capsule
The meticulous powder oral drugs of the Chinese medicine powder that if desired above-mentioned steps (3) is obtained with fill capsule device maneuver routinely, is dressed up 0.5 gram/capsules, and the reuse plastic bottle capsule of packing into seals.
In the method according to manufacturing treatment apoplexy oral drugs medicine ' Suyusan ' for treating provided by the invention, the Chinese medicine extraction jar is that commercially available Chinese medicine extraction jar is generally adopted in this area in the described step (1), and extracting method also is known communication method using common.Described suitable quantity of water consumption does not have strict the qualification, usually raw material medicament submergence adding can be as the criterion, should not be too much or very little, consider can thoroughly active ingredient be extracted and not increase for a long time and be advisable that the ratio that for example drops into raw material medicament and water is 1: 3 (weight) to concentration step.All there is explanation extraction time when using described Chinese medicine extraction jar.Normal pressure concentration tank and spray drying device and fill capsule device described in described step (2) (3) and (4) all are commercially available equipment known in the art, its working procedure also is regulation, known conventional method, is generally 2-4 weight portion (dropping into raw material medicament total weight parts meter) through the meticulous powder of Chinese medicine that obtains after the spray drying.
The meticulous pulvis that is obtained by step (3) can directly be used as oral drugs, for the ease of oral, usually can be processed into various forms of oral drugs, as tablet, granule or capsule etc., be preferably the capsule oral medicine, so, if desired, the meticulous powder that obtains in the step (3) can be become the capsule of 0.5 gram/grain by the fill of fill capsule device.
The oral drugs medicine ' Suyusan ' for treating of treatment apoplexy provided by the invention adapts to various types of apoplexies and cerebral atrophy, arteriosclerosis in use.
Consumption: serious symptom, once obey 4-6 grain (referring to capsule), clothes were 3 times on 1st.Light disease decrement.
Treatment apoplexy oral drugs medicine ' Suyusan ' for treating characteristics provided by the invention are:
1, instant effect: generally can tell on 6-8 days medicines.
2, the treatment phase is short: can cure in general patient 16-30 days.
3, effective percentage and cure rate height are cured the back and are difficult for recurrence, and effective percentage is about 93.94%, and cure rate is about 50.76%.
4, pure Chinese medicinal preparation has no side effect through clinical observation for many years.
5, because the refinement dosage is few, taking convenience.
The present invention will further specify the present invention with the following example, but protection scope of the present invention is not limited to the embodiment of the invention, and those of ordinary skill is changed prescription of the present invention and method in the art, still in protection domain of the present invention.
Embodiment 1
With Rhizoma Acori Graminei, Ramulus Uncariae Cum Uncis, Flos Chrysanthemi, Radix Curcumae, the Radix Aucklandiae, Radix Angelicae Sinensis, Rhizoma Chuanxiong, Radix Salviae Miltiorrhizae, Flos Carthami, the Rhizoma Pinelliae, Pericarpium Citri Reticulatae, Bombyx Batryticatus, Pheretima, put into the Chinese medicine extraction jar by weight in the table 1 and 108 kilograms of pure water, with conventional known extraction method extract Chinese medicine decoction.Then the Chinese medicine decoction that obtains is condensed into thickness Chinese medicine unguentum in the normal pressure concentration tank.The reuse spray drying device, dry above-mentioned Chinese medicine unguentum gets 14.4 kilograms in the meticulous powder of Chinese medicine, and then dresses up the capsule of 0.5 gram/grain with the fill capsule device.
Table 1
| Embodiment 1 | Embodiment 2 | Embodiment 3 | |
| Rhizoma Acori Graminei (kilogram) | 10 | 8 | 15 |
| Ramulus Uncariae Cum Uncis (kilogram) | 2 | 1.2 | 2.5 |
| Flos Chrysanthemi (kilogram) | 2 | 1.1 | 2.5 |
| The Radix Aucklandiae (kilogram) | 2 | 1.8 | 3 |
| Radix Curcumae (kilogram) | 2 | 1.8 | 2.3 |
| Radix Angelicae Sinensis (kilogram) | 1 | 0.9 | 1.3 |
| Rhizoma Chuanxiong (kilogram) | 1 | 0.6 | 1.3 |
| Radix Salviae Miltiorrhizae (kilogram) | 10 | 8 | 15 |
| Flos Carthami (kilogram) | 2 | 1.9 | 2.4 |
| The Rhizoma Pinelliae (kilogram) | 1 | 0.6 | 1.2 |
| Pericarpium Citri Reticulatae (kilogram) | 1 | 0.7 | 1.4 |
| Bombyx Batryticatus (kilogram) | 1 | 0.8 | 1.5 |
| Pheretima (kilogram) | 1 | 0.4 | 1.1 |
| Pure water (kilogram) | 108 | 83 | 151 |
Embodiment 2
Embodiment 2 manufacturing steps are identical with the step of embodiment 1, and different is its consumption is shown in (embodiment 2) in the table 1, and wherein the meticulous powder of De Chinese medicine is 11.12 kilograms.
Embodiment 3
Embodiment 3 manufacturing steps are identical with the step of embodiment 1, and different is its consumption is shown in (embodiment 3) in the table 1, and wherein the meticulous powder of De Chinese medicine is 20.2 kilograms.
The clinical observation result of treatment apoplexy oral drugs medicine ' Suyusan ' for treating curative effect provided by the invention is as shown in table 2 below:
Table 2 from year day in January day to 2000 in January, 1997 Hebei water-saving county cerebrovascular institute use 132 of oral drugs medicine ' Suyusan ' for treating treatment apoplexy cases of the present invention
The state of an illness is followed up a case by regular visits to: follow up a case by regular visits to case 20 people in 180 days and follow up a case by regular visits to case 23 people in 360 days and follow up a case by regular visits to case 67 people after 3 years
| The case number | Sex | Number | Each age group (year) | Symptom before going to a doctor | Therapeutic effect | Mean age | The mean treatment natural law | |||||
| The initial stage number | Mid-term number | The later stage number | Effective transference cure 36-69% | Produce effects transference cure 70-94% | Cure transference cure 95-99% | Invalid transference cure is below 35% | ||||||
| 1 | The man | 1 | 10-19 | 1 | 1 | 13 | 8 | |||||
| The woman | ||||||||||||
| 1 | The man | 1 | 20-29 | 1 | 1 | 27 | 12 | |||||
| The woman | ||||||||||||
| 3 | The man | 2 | 30-39 | 2 | 1 | 3 | 36.6 | 15.6 | ||||
| The woman | 1 | |||||||||||
| 8 | The man | 5 | 40-49 | 6 | 2 | 1 | 1 | 6 | 46.8 | 28.6 | ||
| The woman | 3 | |||||||||||
| 14 | The man | 10 | 50-59 | 5 | 9 | 3 | 3 | 8 | 56.7 | 30.6 | ||
| The woman | 4 | |||||||||||
| 26 | The man | 18 | 60-69 | 7 | 19 | 5 | 4 | 16 | 1 | 67.3 | 32.3 | |
| The woman | 8 | |||||||||||
| 47 | The man | 32 | 70-79 | 6 | 41 | 13 | 10 | 21 | 3 | 76.6 | 33.8 | |
| The woman | 15 | |||||||||||
| 32 | The man | 22 | 80-89 | 2 | 30 | 10 | 7 | 11 | 4 | 86.3 | 36.6 | |
| The woman | 10 | |||||||||||
| Close 132 | Man 91 | Woman 41 | 3 | 28 | 101 | 32 | 25 | 67 | 8 | 71.45 | 32.75 | |
Curative effect: through Laishui County statistics bureau statistical procedures, effective percentage is 93.94% ± 5.16, and cure rate is 50.76% ± 2.13
The efficacy assessment standard of medicine of the present invention is as follows in the last table:
(1) effective: transference cure 36-69% is assessed as effectively.
(2) produce effects: transference cure 70-94% is assessed as produce effects.
(3) cure: transference cure 95-99% is assessed as healing.
(4) invalid: it is invalid that transference cure is assessed as below 36%.
Laishui County, Hebei province institute of traditional Chinese medicine two groups of therapeutic effect in year January in January, 1997-2000 are observed and other the results are shown in table 3-4:
1. two groups of usings method and medicine are respectively the treatment group and use " medicine ' Suyusan ' for treating of the present invention " oral drugs, obey every day three times, press adaptive capacity at every turn and obey.
Matched group uses doctor trained in Western medicine " the molten therapy of fastening ".
2. observe the course of treatment: two groups was a course of treatment with 30 days all, observed continuously 60 days.
Table 3 treatment group is from day to 2000 in January, 1997 year day in January Hebei province Laishui County institute of traditional Chinese medicine use medicine ' Suyusan ' for treating oral drug therapy apoplexy case 49 examples of the present invention
The treatment group: effective percentage is that 93.88% cure rate is 57.14% mean treatment natural law 31.65 days
| The case number | Sex | Number | Each age group (year) | Symptom before going to a doctor | Therapeutic effect | Mean age | The mean treatment natural law | |||||
| The initial stage number | Mid-term number | The later stage number | Effective transference cure 36-69% | Produce effects transference cure 70-94% | Cure transference cure 95-99% | Invalid transference cure is below 35% | ||||||
| The man | 10-19 | |||||||||||
| The woman | ||||||||||||
| The man | 20-29 | |||||||||||
| The woman | ||||||||||||
| The man | 30-39 | |||||||||||
| The woman | ||||||||||||
| 4 | The man | 3 | 40-49 | 1 | 2 | 1 | 1 | 3 | 46.3 | 26.3 | ||
| The woman | 1 | |||||||||||
| 7 | The man | 4 | 50-59 | 2 | 3 | 2 | 1 | 2 | 4 | 56.1 | 28.6 | |
| The woman | 3 | |||||||||||
| 13 | The man | 7 | 60-69 | 1 | 6 | 6 | 4 | 8 | 1 | 66.8 | 31.2 | |
| The woman | 6 | |||||||||||
| 25 | The man | 13 | 70-79 | 2 | 12 | 11 | 2 | 8 | 13 | 2 | 75.3 | 33.6 |
| The woman | 12 | |||||||||||
| The man | 80-89 | |||||||||||
| The woman | ||||||||||||
| Close 49 | Man 27 | Woman 22 | 6 | 23 | 20 | 3 | 15 | 28 | 3 | 66.1 | 31.6 5 | |
Table 4 matched group is from day to 2000 in January, 1997 year molten method Drug therapy apoplexy case 149 examples of fastening of day in January Hebei province Laishui County institute of traditional Chinese medicine use doctor trained in Western medicine
Matched group: effective percentage is that 75.51% cure rate is 42.86% mean treatment natural law 58.57 days
| The case number | Sex | Number | Each age group (year) | Symptom before going to a doctor | Therapeutic effect | Mean age | The mean treatment natural law | |||||
| The initial stage number | Mid-term number | The later stage number | Effective transference cure 36-69% | Produce effects transference cure 70-94% | Cure transference cure 95-99% | Invalid transference cure is below 35% | ||||||
| The man | 10-19 | |||||||||||
| The woman | ||||||||||||
| The man | 20-29 | |||||||||||
| The woman | ||||||||||||
| The man | 30-39 | |||||||||||
| The woman | ||||||||||||
| 4 | The man | 3 | 40-49 | 1 | 2 | 1 | 1 | 2 | 1 | 46.6 | 36.6 | |
| The woman | 1 | |||||||||||
| 7 | The man | 4 | 50-59 | 2 | 3 | 2 | 1 | 1 | 3 | 2 | 55.3 | 42.3 |
| The woman | 3 | |||||||||||
| 13 | The man | 7 | 60-69 | 1 | 6 | 6 | 1 | 3 | 6 | 3 | 66.4 | 54.8 |
| The woman | 6 | |||||||||||
| 25 | The man | 13 | 70-79 | 2 | 12 | 11 | 3 | 6 | 10 | 6 | 72.6 | 68.6 |
| The woman | 12 | |||||||||||
| The man | 80-89 | |||||||||||
| The woman | ||||||||||||
| Close 49 | Man 27 | Woman 22 | 6 | 23 | 20 | 5 | 11 | 21 | 12 | 66.36 | 58.57 | |
It is as follows that Laishui County, Hebei province institute of traditional Chinese medicine carries out two groups of comparative results:
(1) treatment group: effective percentage is 93.88%, and cure rate is 57.14%, and the mean treatment phase is 31.65 days.
(2) matched group: effective percentage is 75.51%, and cure rate is 42.86%, and the mean treatment phase is 58.57 days.
Treatment is organized in 49 cases: male's 27 examples wherein, and women's 22 examples, the age is at 40-80 between year, 66.1 years old mean age.In matched group 49 cases: male's 27 examples wherein, women's 22 examples, the age is at 40-80 between year, 66.36 years old mean age.
According to male, women and the two groups of mean aves before above two groups of treatments, average period of disease, average disease symptom, by these four analyses before going to a doctor, difference does not have the significance meaning between two groups, and it is more reasonable, balanced to illustrate that grouping is controlled in this examination, has neat same comparability.
8, two groups of data contrast efficacy analysis:
The effective percentage of treatment group, cure rate are apparently higher than matched group, and the treatment group treatment phase is short, effect is fast.Two groups of differences all have the significance meaning.Clinical observation shows: treatment group effective percentage is higher than matched group 18.37, and treatment group cure rate is higher than matched group 14.28.The treatment group mean treatment phase was lower than matched group 26.92 days, and the treatment group does not have the side effect of appearance, and matched group has 3 examples side effect to occur.
Claims (5)
1, a kind of treatment apoplexy oral drugs, it is characterized in that by following materials of weight proportions, through extracting, concentrate, dry and the oral drugs powder made: Rhizoma Acori Graminei 8-15 part Ramulus Uncariae Cum Uncis 1.2-2.5 part Flos Chrysanthemi 1.1-2.5 part Radix Curcumae 1-3 part Radix Aucklandiae 1.6-2.5 part Radix Angelicae Sinensis 0.7-1.5 part Rhizoma Chuanxiong 0.5-1.5 part Radix Salviae Miltiorrhizae 8-15 part Flos Carthami 1.8-2.4 part Rhizoma Pinelliae 0.4-1.3 part Pericarpium Citri Reticulatae 0.6-1.5 part Bombyx Batryticatus 0.8-1.5 part Pheretima 0.3-1.4 part.
2, according to the treatment apoplexy oral drugs of claim 1, it is characterized in that described raw material weight proportioning is: Rhizoma Acori Graminei 9-13 part Ramulus Uncariae Cum Uncis 1.5-2.3 part Flos Chrysanthemi 1.2-2.3 part Radix Curcumae 1.8-2.5 part Radix Aucklandiae 1.8-2.3 part Radix Angelicae Sinensis 0.9-1.3 part Rhizoma Chuanxiong 0.6-1.3 part Radix Salviae Miltiorrhizae 9-15 part Flos Carthami 1.9-2.3 part Rhizoma Pinelliae 0.6-1.2 part Pericarpium Citri Reticulatae 0.7-1.4 part Bombyx Batryticatus 0.9-1.4 part Pheretima 0.4-1.1 part.
3, according to the treatment apoplexy oral drugs of claim 1, it is characterized in that described raw material weight proportioning is: 1 part of 1 part of Pheretima of 1 part of Bombyx Batryticatus of 1 part of Pericarpium Citri Reticulatae of 2 parts of Rhizoma Pinelliaes of 10 parts of Flos Carthamis of 1 part of Radix Salviae Miltiorrhizae of 1 part of Rhizoma Chuanxiong of 2 parts of Radix Angelicae Sinensis of 2 parts of Radix Aucklandiae of 2 portions of Radix Curcumaes of 2 parts of Flos Chrysanthemis of 10 parts of Ramulus Uncariae Cum Uncis of Rhizoma Acori Graminei.
4, a kind of manufacture method for the treatment of the apoplexy oral drugs comprises the following steps:
(1) extracts Chinese medicine decoction
With Rhizoma Acori Graminei, Ramulus Uncariae Cum Uncis, Flos Chrysanthemi, Radix Curcumae, the Radix Aucklandiae, Radix Angelicae Sinensis, Rhizoma Chuanxiong, Radix Salviae Miltiorrhizae, Flos Carthami, the Rhizoma Pinelliae, Pericarpium Citri Reticulatae, Bombyx Batryticatus, Pheretima, put into the Chinese medicine extraction jar by arbitrary described weight proportion of claim 1-3 and appropriate amount of purified water, use conventional extraction method, extract Chinese medicine decoction;
(2) concentrate
The Chinese medicine decoction that above-mentioned steps (1) is obtained with the normal pressure concentration tank routinely method refine into the Chinese medicine unguentum;
(3) spray drying
The Chinese medicine unguentum that above-mentioned steps (2) is obtained gets the meticulous powder of Chinese medicine with the spray drying device spray drying.
5, a kind of manufacture method for the treatment of the apoplexy oral drugs comprises the following steps:
(1) extracts Chinese medicine decoction
With Rhizoma Acori Graminei, Ramulus Uncariae Cum Uncis, Flos Chrysanthemi, Radix Curcumae, the Radix Aucklandiae, Radix Angelicae Sinensis, Rhizoma Chuanxiong, Radix Salviae Miltiorrhizae, Flos Carthami, the Rhizoma Pinelliae, Pericarpium Citri Reticulatae, Bombyx Batryticatus, Pheretima, put into the Chinese medicine extraction jar by arbitrary described weight proportion of claim 1-3 and appropriate amount of purified water, use conventional extraction method, extract Chinese medicine decoction;
(2) concentrate
The Chinese medicine decoction that above-mentioned steps (1) is obtained with the normal pressure concentration tank routinely method refine into the Chinese medicine unguentum;
(3) spray drying
The Chinese medicine unguentum that above-mentioned steps (2) is obtained gets the meticulous powder oral drugs of Chinese medicine with the spray drying device spray drying;
(4) fill
With the meticulous powder of Chinese medicine of above-mentioned steps (3), with fill capsule device maneuver routinely, dress up 0.5 gram/capsules, seal with the plastic bottle capsule of packing into.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB011184973A CN1137713C (en) | 2001-06-01 | 2001-06-01 | Chinese medicine oral preparation for curing apoplectic disease-Suyusan and its preparation method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB011184973A CN1137713C (en) | 2001-06-01 | 2001-06-01 | Chinese medicine oral preparation for curing apoplectic disease-Suyusan and its preparation method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1328843A CN1328843A (en) | 2002-01-02 |
| CN1137713C true CN1137713C (en) | 2004-02-11 |
Family
ID=4663234
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB011184973A Expired - Fee Related CN1137713C (en) | 2001-06-01 | 2001-06-01 | Chinese medicine oral preparation for curing apoplectic disease-Suyusan and its preparation method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1137713C (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104906517B (en) * | 2015-07-01 | 2018-11-27 | 广安先瑜健身有限公司 | It is a kind of treat because of hypertension caused by hemiplegia drug |
| CN105816794A (en) * | 2016-03-30 | 2016-08-03 | 李树波 | Traditional Chinese medicine composition for treating apoplexy |
| CN111991515A (en) * | 2020-09-08 | 2020-11-27 | 贵州中医药大学第一附属医院 | Traditional Chinese medicine composition for treating yin deficiency wind-driving syndrome type apoplexy and preparation method thereof |
-
2001
- 2001-06-01 CN CNB011184973A patent/CN1137713C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1328843A (en) | 2002-01-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1210047C (en) | Medicine for treating cold and preparation method thereof | |
| CN1554413A (en) | Chinese medicine for treating urolithiasis and its preparing method | |
| CN1055638C (en) | Selenium-riched Chinese caterpillar fungus oral liquor and its prepn. method | |
| CN101156920B (en) | Oral administration and externally used drug for treating traumatic injury and its preparation method | |
| CN1137713C (en) | Chinese medicine oral preparation for curing apoplectic disease-Suyusan and its preparation method | |
| CN101757455A (en) | Traditional Chinese medicine preparation for treating epilepsy | |
| CN1212127C (en) | Medicated sanitary article for treating gynopathy and its preparation | |
| CN1903352A (en) | Medicine for treating beriberi | |
| CN1895593A (en) | Medicine for treating acne and its preparation | |
| CN1285354C (en) | Medicine for treating cerebral infarction | |
| CN107137455A (en) | A kind of pharmaceutical composition, preparation and purposes | |
| CN1273169C (en) | Medicine for external application for gout and its preparing method | |
| CN1127968C (en) | Oral powder medicine Xiaobaisan for treating leukotrichia and its preparation method | |
| CN1173718C (en) | Medicine for curing lupus erythematosus etc. immune diseases induced diseases | |
| CN1111055C (en) | Ichthyosis treating cream and its preparation | |
| CN1520859A (en) | Cerebrovascular and cardiovascular disease treating injection containing red-rooted salvia and safflower | |
| CN1319415A (en) | Pill medicine for treating cardio-cerebro vascular diseases | |
| CN1186036C (en) | Diabetes treating medicine and its prepn | |
| CN1264592A (en) | Medicine for treating ichthyosis and preparing process thereof | |
| CN1270038A (en) | Fumigant lotion for treating anorectal disease and preparing process thereof | |
| CN1269499C (en) | Medicine efficacious for burn and preparation method | |
| CN1650943A (en) | Medicine for treating high blood pressure disease | |
| CN101612321A (en) | Traditional Chinese medicine for treating facial paralysis and prosopodynia | |
| CN1435217A (en) | Bone-strengthening medicine and producing method thereof | |
| CN1923230A (en) | Medicine for treating rheumatism and rheumatoid disease, and its preparation method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20040211 Termination date: 20130601 |